Related Experiment Video
Updated: Dec 4, 2025

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
Endoscopic imaging in inflammatory bowel disease: current developments and emerging strategies
Jouke J H van der Laan1, Anne M van der Waaij1, Ruben Y Gabriëls1
1Department of Gastroenterology and Hepatology, University Medical Centre Groningen , Groningen, The Netherlands.
Advanced endoscopy and artificial intelligence improve inflammatory bowel disease (IBD) assessment. Molecular and label-free imaging offer new ways to visualize biomarkers, aiding in healing and dysplasia detection for better IBD patient outcomes.
Area of Science:
- Gastroenterology and Endoscopic Imaging
- Biomedical Engineering
- Molecular Diagnostics
Background:
- Enhanced and magnified endoscopy represent significant advancements in imaging ileocolonic pathology in inflammatory bowel disease (IBD).
- Artificial intelligence (AI) is increasingly integrated to enhance these advanced endoscopic techniques.
- Challenges in IBD management include therapy non-response and delayed/missed detection of neoplastic lesions during surveillance.
Purpose of the Study:
- To review the clinical applications of advanced endoscopic imaging modalities in IBD.
- To explore the potential of molecular imaging and label-free techniques to address current limitations in IBD assessment.
- To evaluate the role of AI in augmenting endoscopic capabilities for IBD.
Main Methods:
- A comprehensive literature search was performed in PubMed/MEDLINE up to May 2020.
- The search focused on preclinical and clinical applications of various endoscopic techniques in IBD.
- Key technologies reviewed include high-definition white light endoscopy, chromoendoscopy, AI, confocal laser endomicroscopy, endocytoscopy, molecular imaging, optical coherence tomography, and Raman spectroscopy.
Main Results:
- Enhanced and magnified endoscopy have improved the assessment of the ileocolonic mucosa in IBD.
- Molecular imaging provides functional data by visualizing biological parameters, complementing morphological assessment.
- Label-free modalities offer visualization beyond the mucosal surface without requiring tracers.
Conclusions:
- Molecular imaging integrated into endoscopy can provide real-time in vivo visualization of biomarkers, addressing clinical challenges in IBD.
- Label-free modalities hold promise for optimizing the endoscopic evaluation of mucosal healing and dysplasia detection in IBD patients.
- These advanced imaging techniques, including AI, are poised to improve IBD diagnosis and surveillance.
More Related Videos
09:42Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation
Published on: August 26, 2014
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...